Related Experiment Videos
Nosocomial pneumonia guidelines: an international perspective
1Division of Infectious Disease, McMaster University, Hamilton, Ontario, Canada.
Chest
|March 27, 1998
Summary
Hospital-acquired pneumonia (HAP) management is complex. This study reviews international guidelines for HAP treatment, highlighting variations and controversial aspects among infectious disease experts.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Public Health
Background:
- Hospital-acquired pneumonia (HAP) presents significant morbidity and mortality.
- Effective management requires careful consideration of diverse clinical factors.
- Existing treatment guidelines aim to standardize care for HAP.
Purpose of the Study:
- To review existing national and hospital-based guidelines for HAP management.
- To identify and discuss controversial issues in nosocomial pneumonia treatment.
- To compare guideline availability across different countries.
Main Methods:
- A questionnaire was distributed to infectious disease physicians and clinical microbiologists in 29 countries.
- The survey assessed the existence and scope of HAP treatment guidelines.
- A review of identified guidelines and related controversial topics was conducted.
Main Results:
- Canada and the United States have established national HAP guidelines.
- Australia, Sweden, and France also possess national guidelines.
- Some countries, like Hong Kong and France, have hospital-specific guidelines.
Conclusions:
- Guideline development for HAP varies internationally.
- Understanding these variations is crucial for optimizing patient care.
- Further discussion on controversial HAP management issues is warranted.